No. |
Name |
CAS No. |
Remark |
161 |
(Bromomethyl)cyclopropane |
7051-34-5 |
Tropane APIs key intermedates |
162 |
2,5-Dimethoxytetrahydrofuran |
696-59-3 |
Tropane APIs key intermedates |
163 |
4-Ethyl-5-fluoro-6-hydroxypyrimidine |
137234-87-8 |
Voriconazole |
164 |
9-benzyl-9azabicyclo[3.3.1]nonan-3-one |
2291-58-9 |
OBB |
165 |
(2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-50-2 |
LCZ696 |
166 |
1-cyclopropyl-4-isothiocyanatonaphthalene |
878671-95-5 |
Lesinurad |
167 |
4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol |
1533519-84-4 |
Lesinurad |
168 |
2 - [[4- (4-cyclopropyl-naphthalen-1-yl) -4H-1,2,4- triazol-3-yl]thiol] acetate |
1533519-85-5 |
Lesinurad |
169 |
4-hydroxy-N,N-diphenyl-(4R)-2-Pentynamide |
899809-61-1 |
Vorapazar Sulfate |
170 |
(E)-3-(5-Nitrocyclohex-1-en-1-yl)acrylic acid |
899809-64-4 |
Vorapazar Sulfate |
171 |
(3R, 3AS, 4S, 4AS, 7R, 9AR) -1,3,3A, 4,4A, 5,6,7,8,9A-decahydro-3-methyl-7-nitro-1-oxo-N, N-diphenyl-naphtho [2,3-C] furan-4-carboxamide |
900186-72-3 |
Vorapazar Sulfate |
172 |
[(1R, 3aR, 4aR, 6R, 8aR, 9S, 9aS) -9 - [(diphenylamino) carbonyl]dodeca hydro-1-methyl-3-oxo-naphtho [2,3-c] 6-yl] ethyl carbamate |
900161-12-8 |
Vorapazar Sulfate |
173 |
[[5-(3-Fluorophenyl)-2-pyridinyl]methyl]phosphonic acid diethylester |
380894-77-9 |
Vorapazar Sulfate |
174 |
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H |
163706-58-9 |
Cangrelor |
175 |
2,4,5-trifluoro-b-oxobenzenepropanoic acid ethylester >98% |
98349-24-7 |
DFSX-2 |
176 |
3,5-Difluoropyridine-2,6-diamine |
247069-27-8 |
DFSX-2 |
177 |
3-Hydroxyazetidine hydrochloride |
18621-18-6 |
DFSX-2 |
178 |
5-methyl-3,4-diphenyl-isoxazole |
37928-17-9 |
Parecoxib Sodium |
179 |
2-Aminopropanediamide |
62009-47-6 |
|
180 |
Diethyl aminomalonate hydrochloride |
13433-00-6 |
|
This list is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights. |